Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Quinoxaline Compound
Abstract: [Problem] Provided is a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like. [Means for Solution] The present inventors have investigated a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like, and thus, have found that an imidazoquinoxaline compound or a triazoloquinoxaline compound has a PDE9-inhibiting action, thereby completing the present invention. The imidazoquinoxaline compound or the triazoloquinoxaline compound of the present invention has a PDE9-inhibiting action and can be used as an agent for preventing and/or treating storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
05 September 2011
Publication Number
47/2012
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Applicants
ASTELLAS PHARMA INC.
3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 1038411
Inventors
1. KAIZAWA, HIROYUKI
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 1038411
2. SUGITA, MARI
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 1038411
3. AZAMI, HIDENORI
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 1038411
4. SEO, RYUSHI
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 1038411
5. NOMURA, TAKAHO
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 1038411
6. YAMAMOTO, SATOSHI
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 1038411
7. YAMAMOTO, HIROFUMI
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 1038411
8. TSUCHIYA, KAZUYUKI
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 1038411
9. KUBOTA, HIDEKI
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 1038411
10. KAMIJO, KAZUNORI
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 1038411
Specification
ATTACHED
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 6337-CHENP-2011-AbandonedLetter.pdf | 2018-02-12 |
| 1 | Form13_Change in Specification_05-09-2011.pdf | 2011-09-05 |
| 2 | 6337-CHENP-2011 POWER OF ATTORNEY 05-09-2011.pdf | 2011-09-05 |
| 2 | 6337-CHENP-2011-FER.pdf | 2017-07-27 |
| 3 | 6337-CHENP-2011 PCT 05-09-2011.pdf | 2011-09-05 |
| 3 | 6337-CHENP-2011 CORRESPONDENCE OTHERS 06-05-2015.pdf | 2015-05-06 |
| 4 | 6337-CHENP-2011 FORM-5 05-09-2011.pdf | 2011-09-05 |
| 4 | 6337-CHENP-2011 ENGLISH TRANSLATION 06-05-2015.pdf | 2015-05-06 |
| 5 | 6337-CHENP-2011 FORM-3 05-09-2011.pdf | 2011-09-05 |
| 5 | 6337-CHENP-2011 ENGLISH TRANSLATION-1 06-05-2015.pdf | 2015-05-06 |
| 6 | 6337-CHENP-2011 FORM-2 05-09-2011.pdf | 2011-09-05 |
| 6 | 6337-CHENP-2011 ENGLISH TRANSLATION-2 06-05-2015.pdf | 2015-05-06 |
| 7 | 6337-CHENP-2014 FORM-3 30-06-2014...pdf | 2014-06-30 |
| 7 | 6337-CHENP-2011 FORM-13 05-09-2011.pdf | 2011-09-05 |
| 8 | 6337-CHENP-2014 FORM-3 30-06-2014.pdf | 2014-06-30 |
| 8 | 6337-CHENP-2011 FORM-1 05-09-2011.pdf | 2011-09-05 |
| 9 | 6337-CHENP-2011 CORRESPONDENCE OTHERS 22-02-2012.pdf | 2012-02-22 |
| 9 | 6337-CHENP-2011 DESCRIPTION(COMPLETE) 2 05-09-2011.pdf | 2011-09-05 |
| 10 | 6337-CHENP-2011 DESCRIPTION(COMPLETE) 1 05-09-2011.pdf | 2011-09-05 |
| 10 | 6337-CHENP-2011 FORM-3 22-02-2012.pdf | 2012-02-22 |
| 11 | 6337-CHENP-2011 ABSTRACT 05-09-2011.pdf | 2011-09-05 |
| 11 | 6337-CHENP-2011 DESCRIPTION(COMPLETE) 05-09-2011.pdf | 2011-09-05 |
| 12 | 6337-CHENP-2011 CLAIMS 05-09-2011.pdf | 2011-09-05 |
| 12 | 6337-CHENP-2011 CORRESPONDENCE OTHERS 05-09-2011.pdf | 2011-09-05 |
| 13 | 6337-CHENP-2011 CLAIMS 05-09-2011.pdf | 2011-09-05 |
| 13 | 6337-CHENP-2011 CORRESPONDENCE OTHERS 05-09-2011.pdf | 2011-09-05 |
| 14 | 6337-CHENP-2011 ABSTRACT 05-09-2011.pdf | 2011-09-05 |
| 14 | 6337-CHENP-2011 DESCRIPTION(COMPLETE) 05-09-2011.pdf | 2011-09-05 |
| 15 | 6337-CHENP-2011 DESCRIPTION(COMPLETE) 1 05-09-2011.pdf | 2011-09-05 |
| 15 | 6337-CHENP-2011 FORM-3 22-02-2012.pdf | 2012-02-22 |
| 16 | 6337-CHENP-2011 CORRESPONDENCE OTHERS 22-02-2012.pdf | 2012-02-22 |
| 16 | 6337-CHENP-2011 DESCRIPTION(COMPLETE) 2 05-09-2011.pdf | 2011-09-05 |
| 17 | 6337-CHENP-2014 FORM-3 30-06-2014.pdf | 2014-06-30 |
| 17 | 6337-CHENP-2011 FORM-1 05-09-2011.pdf | 2011-09-05 |
| 18 | 6337-CHENP-2014 FORM-3 30-06-2014...pdf | 2014-06-30 |
| 18 | 6337-CHENP-2011 FORM-13 05-09-2011.pdf | 2011-09-05 |
| 19 | 6337-CHENP-2011 FORM-2 05-09-2011.pdf | 2011-09-05 |
| 19 | 6337-CHENP-2011 ENGLISH TRANSLATION-2 06-05-2015.pdf | 2015-05-06 |
| 20 | 6337-CHENP-2011 FORM-3 05-09-2011.pdf | 2011-09-05 |
| 20 | 6337-CHENP-2011 ENGLISH TRANSLATION-1 06-05-2015.pdf | 2015-05-06 |
| 21 | 6337-CHENP-2011 FORM-5 05-09-2011.pdf | 2011-09-05 |
| 21 | 6337-CHENP-2011 ENGLISH TRANSLATION 06-05-2015.pdf | 2015-05-06 |
| 22 | 6337-CHENP-2011 PCT 05-09-2011.pdf | 2011-09-05 |
| 22 | 6337-CHENP-2011 CORRESPONDENCE OTHERS 06-05-2015.pdf | 2015-05-06 |
| 23 | 6337-CHENP-2011-FER.pdf | 2017-07-27 |
| 23 | 6337-CHENP-2011 POWER OF ATTORNEY 05-09-2011.pdf | 2011-09-05 |
| 24 | Form13_Change in Specification_05-09-2011.pdf | 2011-09-05 |
| 24 | 6337-CHENP-2011-AbandonedLetter.pdf | 2018-02-12 |
Search Strategy
| 1 | SearchStrategyandreport_24-07-2017.pdf |